🇺🇸 FDA
Pipeline program

Intravenous Carbamazepine (IV CBZ)

13181A

Phase 3 small_molecule completed

Quick answer

Intravenous Carbamazepine (IV CBZ) for Epilepsy is a Phase 3 program (small_molecule) at LIGAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
LIGAND PHARMACEUTICALS INC
Indication
Epilepsy
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials